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a b s t r a c t
The evolutionarily conservedMEC1 checkpoint pathway mediates cell cycle arrest and induction of genes
including the RNR (Ribonucleotide reductase) genes and HUG1 (Hydroxyurea, ultraviolet, and gamma
radiation) in response to DNA damage and replication arrest. Rnr complex activity is in part controlled
by cytoplasmic localization of the Rnr2p–Rnr4p subunits and inactivation of negative regulators Sml1p
and Dif1p upon DNA damage and hydroxyurea (HU) treatment. We previously showed that a deletion
of HUG1 rescues lethality of mec1D and suppresses dun1D strains. In this study, multiple approaches
demonstrate the regulatory response of Hug1p to DNA damage and HU treatment and support its role
as a negative effector of the MEC1 pathway. Consistent with our hypothesis, wild-type cells are sensitive
to DNA damage and HU when HUG1 is overexpressed. A Hug1 polyclonal antiserum reveals that HUG1
encodes a protein in budding yeast and its MEC1-dependent expression is delayed compared to the rapid
induction of Rnr3p in response to HU treatment. Cell biology and subcellular fractionation experiments
show localization of Hug1p-GFP to the cytoplasm upon HU treatment. The cytoplasmic localization of
Hug1p-GFP is dependent on MEC1 pathway genes and coincides with the cytoplasmic localization of
Rnr2p–Rnr4p. Taken together, the genetic interactions, gene expression, and localization studies support
a novel role for Hug1p as a negative regulator of theMEC1 checkpoint response through its compartmen-
talization with Rnr2p–Rnr4p.
Published by Elsevier Inc.
1. Introduction
Cellular survival in response to DNA lesions and replication
arrest requires the coordination of checkpoint-mediated mecha-
nisms to ensure DNA damage repair, cell cycle arrest, and recovery
for genome stability. Checkpoint pathways regulate the expression
of protein kinases, which mediate a transcriptional response and
cell cycle arrest through downstream effectors. In Saccharomyces
cerevisiae, the evolutionarily conserved MEC1 (ortholog to the
human ataxia telangiectasia mutated- and Rad3-related – ATR –
protein) checkpoint pathway regulates origin firing, fork progres-
sion, and DNA repair and recovery (reviewed in [1]).
Mec1p and its effector kinases, Rad53p and Dun1p, activate
both positive and negative effectors that regulate deoxyribonucle-
otide (dNTP) pools, cell cycle arrest, and recovery [1]. The activity
of the positive effector RNRs (Ribonucleotide reductases), which
are responsible for the rate-limiting conversion step of ribonucleo-
tides (rNDPs) to dNTPs, is tightly regulated. The homodimer Rnr1p
and the heterodimers Rnr2p and Rnr4p, which compose the Rnr
complex, are transcriptionally repressed by Crt1 [2,3] while Rnr1p
contains binding sites for dATP allosteric inhibition [4]. In the ab-
sence of DNA damage, negative regulators such as Sml1p and Dif1p
regulate Rnr complex activity through inhibition of the Rnr sub-
unit, Rnr1p, and by subcellular compartmentalization of the
Rnr2p–Rnr4p subunits to the nucleus [5,6]. However, in response
to DNA damage or replication arrest, Sml1p and Dif1p are phos-
phorylated and degraded [5,7]. This, along with the transcriptional
induction of RNRs and localization of the Rnr complex to the cyto-
plasm, serves to increase dNTP pools [5,7,8]. Checkpoint mediated
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response to DNA damage and replication arrest has been studied
extensively, however we do not fully understand how cells recover
from checkpoint arrest and downregulate Rnr activity to maintain
genome stability.
In this paper, we examined the role of Hug1p (Hydroxyurea,
Ultraviolet, Gamma) as a negative regulator of the MEC1 pathway.
HUG1 is one of the most differentially expressed genes identified in
a screen for gene expression in response to HU treatment [9]. Un-
like SML1 and DIF1, the transcription of HUG1 is induced in cells
treated with HU or exposed to ultraviolet or gamma radiation in
aMEC1-dependent manner [2]. A deletion of HUG1 has been shown
to rescue lethality due to a MEC1 null allele and suppress the HU
sensitivity of dun1D mutants [2]. Studies with HUG1 have primar-
ily focused on its transcriptional response to replication arrest and
DNA damage [2,10–13]. Using a polyclonal serum to Hug1p, we
have shown that HUG1 encodes for a protein. Our results for
HUG1 overexpression phenotypes, a delayed induction pattern of
Hug1p in response to HU treatment, and the MEC1-dependent
compartmentalization of Hug1p in response to replication arrest
define a novel role for Hug1p as a negative regulator of the
MEC1-checkpoint response through its compartmentalization with
Rnr2p–Rnr4p [14].
2. Materials and methods
2.1. Strains, plasmids, cell cycle arrest with HU and growth sensitivity
to HU, MMS and BLM
Strains and plasmids are described in Supplementary Table 1.
Transformations, cloning, and cell culture were performed using
standard methods as previously described [2,15–17]. Additional
strain and expression vector construction procedures are outlined
in the supplementary materials and methods. Primer sequences
are available upon request. Cell cycle arrest with 0.1 M HU (Fluka
Chemika) was as described [2]. Cells (>90%) exhibited a large bud-
ded phenotype with S-phase DNA content, as determined by flow
cytometry using an Accuri C6 flow cytometer (BD Accuri Cytome-
ters) [18]. Serial dilutions of cells grown in medium selective for
the plasmid were assayed for growth with dextrose (2%) or raffi-
nose (2%) plus galactose (2%)with 0.1 MHU, 0.01%MMS (Sigma–Al-
drich), or 5 mU/mL BLM (Bristol-Myers Squibb) as described [18].
2.2. Western blots and subcellular fractionation
Western blots for Hug1p, Hug1p-GFP, Rnr3p-HA, Sir2p, Pgk1p,
Tub2p and subcellular fractionation were performed as described
[18,19] using anti-HA (12CA5 Roche), -GFP (A11122 Invitrogen), -
Sir2p (yN-19) (sc-6666 Santa Cruz), -Pgk1p (459250 Invitrogen),
-Hug1p and -Tub2p (antisera generated in Basrai Laboratory).
2.3. Localization of Hug1p-GFP
Hug1p-GFP expressing strains were grown to exponential phase
in YPD and treated with 0.1 M HU for 3.5 h. For localization of
GAL1-HUG1-GFP, cells were grown to exponential phase in syn-
thetic medium with raffinose (2%) followed by growth in galactose
(2%) medium for 2 h, shifted to dextrose (2%) medium with or
without 0.1 M HU for 3.5 h. Harvested cells were prepared for
microscopy as described [20] except that paraformaldehyde was
the only fixative and Hoechst 33342 (Thermo Scientific) was used
for nuclear staining. Images were acquired using a Zeiss Axio Ob-
server Z1 microscope.
Image deconvolution and analysis were performed in ImageJ
using plug-ins Diffraction PSF 3D to calculate the point-spread-
function and Iterative Deconvolve 3D [21] for deconvolution.
Localization analysis was performed as described [22]. Cytoplasmic
localization was determined empirically to be a nuclear-to-cyto-
plasmic intensiometric ratio below 0.9, even distribution between
0.9 and 1.1, and nuclear localization above 1.1. For each strain, at
least 100 large budding cells with a nucleus at the bud neck were
counted.
Statistical analysis on the subcellular localization data was per-
formed in SAS 9.3 using three-way factorial analysis of variance
(ANOVA) with Tukey’s multiple comparison range test. Additional
statistical analysis is provided in the supplementary materials and
methods.
3. Results
3.1. Overexpression of HUG1 increases the sensitivity of wild-type
strains to HU, MMS and BLM
We have previously shown that a deletion of HUG1 suppresses
the viability of mec1D strains and HU sensitivity of dun1D strains
[2]. Similar results have been reported in the HUG1 paralogs,
DIF1 and SML1, both of which are negative regulators of the Rnr
complex and the checkpoint response [5,7,16]. To determine if
Hug1p acts as a negative regulator of theMEC1 pathway, wild-type
strains overexpressing HUG1 were assayed for growth on media
containing HU and DNA damaging agents. GAL1-HUG1 was found
to increase the sensitivity of wild-type strains to HU on medium
containing galactose (GAL) and 0.15 M HU (Fig. 1A, Row 2). GAL1-
HUG1 or vector (Fig. 1A, Rows 2 and 1, respectively) did not show
growth defects on dextrose (DEX) plates with and without HU and
GAL plates without HU. The phenotype was specifically due to
expression of Hug1p, as a frame-shift mutation in the HUG1 open
reading frame (GAL1-HUG1*) abolished the dosage lethality pheno-
type (data not shown).
Since the viability of mec1D strains is suppressed by sml1-1 or
sml1D[5,7,16], the dosage lethality of GAL1-HUG1 in wild-type
strains was examined for dependence on SML1.Similar to the
wild-type strain, the sml1D strain with GAL1-HUG1 exhibited
growth inhibition on HU containing medium (Fig. 1A, Row 6). Re-
sults verifying that SML1 is not required for the dosage lethality of
strains containing GAL1-HUG1 are supported by recent work
describing the ubiquitylation and subsequent degradation of
Sml1p in response to DNA damage [7]. As expected, the
mec1Dsml1D strain was sensitive to growth on HU containing
plates with or without GAL1-HUG1 (Fig. 1A, Rows 3 and 4).
mec1Dsml1D strains expressing GAL1-HUG1 also showed a slow
growth phenotype even in the absence of HU (Fig. 1A, Row 4, cen-
ter panel). These results are similar to the negative regulator, DIF1,
which displays dosage lethality in mec1Dsml1D strains [5].
In addition to HU sensitivity, GAL1-HUG1 strains exhibited sig-
nificant growth inhibition on MMS and BLM containing media
(Fig. 1B, Row 3) when compared with empty-vector strains
(Fig. 1B, Row 2). As expected, the mec1Dsml1D strain displayed
growth inhibition on plates containing MMS and BLM (Fig. 1B,
Row 1). Taken together, the synthetic dosage lethality of GAL1-
HUG1 strains along with previous data support a role for Hug1p
as a negative regulator of the MEC1-mediated checkpoint response
to DNA damage and replication arrest.
3.2. Expression of Hug1p shows delayed induction to 0.1 M HU
compared to Rnr3p, a positive effector of the MEC1 pathway
Using transcriptome profiling,we previously reported thatHUG1
represents one of the most highly differentially expressed genes in
the yeast genome [2,9]. Initial genome sequencing efforts annotated
all ORFs of at least 100 contiguous codons, hence HUG1 was not
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annotated as it encodes for a protein of 68 amino acids. To validate
that HUG1 encodes for a protein, a rabbit polyclonal serum specific
toHug1pwas generated. Results fromWestern blot analysis corrob-
orated results ofNorthernblot analysis [2], asHug1pexpressionwas
observed in a wild-type strain treated with HU (Fig. 2A, Lane 2). The
control includes a hug1D strain that shows Hug1p expression when
transformedwithaplasmidexpressingHUG1 from itsownpromoter
(pHUG1; Fig. 2A, Lane 6). In agreement with previous results, tup1
and crt1D strains constitutively expressed Hug1p (Fig. 2A, Lanes
7–10). Crt1p, Tup1p and Ssn6p are transcriptional repressors that
bind to X-box sequences in the promoter of HUG1 and RNRs in the
absence of DNA damage and replication arrest [2]. The polyclonal
serum also showed that, in agreement with previous Northern blot
analysis, no HU induced expression of Hug1p was detected in
mec1Dsml1D strains (Fig. 2B, Lane 6) and SML1 was not required
for the expression of Hug1p (Fig. 2B, Lane 4).
To gain further insight into the role ofHug1p,HU inducedexpres-
sion of Hug1p was compared with Rnr3p, a positive regulator of the
MEC1 pathway. Hug1p expressionwas detected 1.5 h post-HU addi-
tion and increased until approximately 3.5 h post-HU addition after
which no further induction was apparent (Fig. 2C). Consistent with
previous reports [3], Rnr3p-HA was detected 30 min post-HU addi-
tion, increased until 90–120 min post-HU addition, and subse-
quently declined (Fig. 2C). The delayed induction of Hug1p with
high levelspresent at3.5–5 hpost-HUaddition resembles theprofile
of Crt1p [3], a negative regulator of RNRs andHUG1 gene expression.
3.3. Hug1p-GFP localizes to the cytoplasm in HU treated cells
The subcellular localization of Hug1p-GFP was analyzed by fus-
ing GFP to the C-terminus of Hug1p expressed from its native pro-
moter at the chromosomal locus in the genome. Western blot
analysis showed expression of Hug1p-GFP in cells treated with
HU (Fig. 3A). Fluorescence microscopy of Hug1p-GFP cells without
HU treatment showed only background fluorescence (Fig. 3B, left
column). However, upon treatment with HU, Hug1p-GFP was en-
riched in the cytoplasm and was notably excluded from the nu-
cleus in 96.3 ± 3.1% of the cells (Fig. 3B, right column). DNA
content measurement by FACS and nuclear morphology of the cells
confirmed S-phase arrest of the HU treated cells (data not shown).
To rule out artifacts in localization due to GFP tagging of Hug1p,
the data were corroborated by subcellular fractionation of cells
expressing non-epitope tagged Hug1p expressed from its native
promoter. Total, nuclear (Nuc) and cytoplasmic (Cyto) fractions
of cells with or without HU were analyzed by Western blot using
anti-Sir2p (nuclear marker), -Pgk1p (cytoplasmic marker) or -
Hug1p. Sir2p was enriched in the nuclear fraction (Fig. 3C, Lane
5) and Pgk1p in the cytoplasmic fraction (Fig. 3C, Lane 6) in HU
treated cells. Hug1p was only observed in the cytoplasmic fraction
of the HU treated cells and was excluded from the nucleus (Fig. 3C,
Lane 6). The enrichment of Hug1p in the cytoplasmic fraction sup-
ports the data showing Hug1p localization to the cytoplasm in HU
treated cells.
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Fig. 1. Overexpression of HUG1 sensitizes growth to HU, BLM and MMS. (A) Serial dilutions of wild-type strain (WT, W1588-4A),mec1Dsml1D (U953-61A) and sml1D (U952-
3B) with vector (pRS316) or GAL1-HUG1 (pMB379) were grown on plates with dextrose (DEX), galactose (GAL) or galactose with 0.15 M HU (GAL + HU) and incubated at 30
for 2–3 days. (B) Serial dilutions of mec1Dsml1D (U953-61A) or hug1D (YMB847) with vector (pRS414-GAL1) or GAL1-HUG1 (pMB394) were grown on plates with galactose
(GAL), galactose with 5 mU/mL BLM (GAL + BLM), or 0.01% MMS (GAL + MMS) and incubated at 30 for 2–3 days.
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Fig. 2. Genes in the MEC1 pathway are required for HU induced expression of
Hug1p and delayed induction of Hug1p compared to Rnr3p. (A) Western blot
analysis of wild-type (WT, YPH499), hug1D (YMB847), hug1D (YMB847) with
pHUG1 (pMB444), tup1D (Y217), crt1D (Y577) grown with or without 0.1 M HU for
3.5 h and probed with anti-Hug1p or -Pgk1p (loading control). (B) Western blot
analysis of wild-type (WT, W1588-4A), sml1D (U952-3C),mec1Dsml1D (U953-61D)
grown with or without 0.1 M HU for 3.5 h (C) Western blot analysis of RNR3-HA
strains (YMB1657) after treatment with 0.1 M HU for various times and probed
with anti-Hug1p, -HA (Rnr3p-HA) and -Tub2p (loading control).
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3.4. Cytoplasmic localization of Hug1p in response to HU treatment is
not merely due to overexpression of the protein
Since HUG1 expression is induced in response to DNA damage
and replication arrest in a checkpoint dependent manner [2], we
examined if the cytoplasmic localization of Hug1p under these
conditions may reflect its high level of expression using cells
expressing GAL1-HUG1-GFP. Western blot analysis showed that
GAL1-HUG1-GFP was expressed in wild-type, mec1Dsml1D, and
sml1D strains grown in galactose medium (Fig. 4A). Cells grown
in the presence of galactose for 2 h, followed by growth in glucose
medium with or without HU were examined for nuclear morphol-
ogy and localization of GAL1-HUG1-GFP. Nuclear-to-cytoplasmic
intensiometric ratios were quantified as described [22] to deter-
mine Hug1p-GFP subcellular compartmentalization for all strains
(Fig. S1). In the absence of HU, Hug1p-GFP was primarily localized
to the nucleus (88.2 ± 2.0%) whereas a majority of the HU treated
cells (86.6 ± 3.3%) exhibited cytoplasmic localization (Fig. 4B,
WT). The similar localization pattern of GAL1-HUG1-GFP to that
of HUG1-GFP expressed under the native HUG1 promoter revealed
that the cytoplasmic localization of Hug1p-GFP is independent of
protein expression levels.
3.5. Cytoplasmic localization of Hug1p-GFP is MEC1-dependent and
coincides with the compartmentalization of Rnr2p–Rnr4p to the
cytoplasm
Since genes in theMEC1 pathway are required for the DNA dam-
age and replication arrest induced expression of Hug1p [2], we
examined whether the cytoplasmic localization of Hug1p is depen-
dent on the MEC1 effector kinases, MEC1, RAD53, and DUN1. In the
absence of HU, Hug1p-GFP mainly localized to the nucleus in
mec1D sml1D strains (92.1 ± 8.5%), similar to that observed in
wild-type strain (88.2 ± 2.0%). However, contrary to the cytoplas-
mic localization of Hug1-GFP in wild-type cells (86.6 ± 3.3%), very
few of the mec1Dsml1D cells showed localization to the cytoplasm
(8.5 ± 1.1%) in response to HU treatment. The majority of Hug1p-
GFP in the mec1Dsml1D cells was nuclear (64.0 ± 7.3%) or was
evenly distributed throughout the cell (27.5 ± 7.0%). The localiza-
tion pattern observed in mec1Dsml1D strains was independent of
SML1 as sml1D strains exhibited a localization pattern more closely
resembling wild-type strains. In the sml1D strain, Hug1p-GFP
localized to the nucleus (97.1 + 1.0%) in the absence of HU and to
the cytoplasm (85.5 ± 2.3%) in the presence HU (Fig. 4B).
We next examined the localization of GAL1-HUG1-GFP in
rad53D and dun1D strains. In the absence of HU, both rad53D
(74.8 ± 11.2%) and dun1D (83.9 ± 0.5%) strains showed nuclear
localization of Hug1p-GFP similar to that observed in the wild-type
strain (Fig. 4B). However, unlike the wild-type cells, in the pres-
ence of HU, only a small fraction of rad53D cells localized to the
cytoplasm (15.7 ± 4.9%) with a majority of the cells exhibiting an
even distribution (46.3 ± 4.5%) or nuclear localization
(37.9 ± 9.3%) of Hug1p-GFP signal. In the presence of HU, the
dun1D strains exhibited a cytoplasmic localization profile of
Hug1p-GFP that was intermediate to the pattern in mec1Dsml1D
and wild-type strains. Cytoplasmic localization was observed in
approximately half the population (52.5 ± 5.0%) of dun1D cells
whereas the remaining cells had either an even distribution
(45.3 ± 4.1%) or nuclear localization (1.9 ± 0.9%) of Hug1p-GFP. Ta-
ken together, these data indicate that Hug1p-GFP localizes to the
cytoplasm in response to HU treatment and this localization is
dependent onMEC1, RAD53, and DUN1 and is independent of SML1.
4. Discussion
Checkpoint mediated recovery from DNA damage and replica-
tion arrest is in part mediated by stringent regulation of Rnr activ-
ity. Negative effectors of the MEC1 pathway, namely SML1 and
DIF1, interact with Rnr complex subunits and regulate its activity
and subcellular compartmentalization. The downregulation of
Dif1p and Sml1p in response to DNA damage or replication arrest
increases dNTP pools [5–7]. However, after recovery from check-
A
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Fig. 3. Hug1p-GFP is localized to the cytoplasm in response to HU treatment. (A)
Western blot analysis showing HU induced expression of HUG1-GFP expressed from
its native promoter at the endogenous locus in wild-type (WT, YPH499), hug1D
(YMB847), and HUG1-GFP (YMB1618) strains grown with or without 0.1 M HU for
3.5 h and probed with anti-GFP or Tub2p (loading control). (B) Cells expressing
Hug1p-GFP grown in the absence (left column) or presence of 0.1 M HU for 3.5 h
(right column) show exclusion from the nucleus. Arrow indicates bud neck; white
line outlines the nucleus; white scale bar length is 5 lm. (C) Total, nuclear (Nuc)
and cytoplasmic (Cyto) fractions of wild-type strains (YPH499) grown in the
absence or presence of 0.1 M HU for 3.5 h analyzed by Western blot using a
polyclonal serum to Hug1p, Sir2p (Nuc), or Pgk1p (Cyto).
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point arrest, Rnr activity must be attenuated by negative regulators
for normal cell cycle progression [5–8,16,23–25]. We propose that
Hug1p is a negative regulator of the MEC1 pathway, which unlike
DIF1 and SML1, is induced in response to DNA damage and replica-
tion arrest. This is based on our results which show that: (a) strains
expressing GAL1-HUG1 are sensitized to growth in the presence of
HU and DNA damaging agents, (b) the temporal pattern of Hug1p
expression in the presence of HU exhibits a lag when compared
with Rnr3p, a positive regulator of the MEC1 pathway, and resem-
bles that of Crt1p, a negative regulator of the MEC1 pathway, and
(c) suppression of lethality of mec1D and HU sensitivity of dun1D
strains by deletion of HUG1.
We propose that Hug1p may serve to negatively regulate the
MEC1 pathway by co-compartmentalization with Rnr2p–Rnr4p to
the cytoplasm in response to HU treatment. The cytosolic localiza-
tion is not simply due to overexpression of Hug1p as corroborated
by localization analysis of GAL1-HUG1-GFP. Consistent with a
requirement of MEC1 pathway genes for the induction of HUG1,
cytoplasmic localization of Hug1p was dependent on MEC1,
RAD53 and DUN1. Interestingly, Hug1p and Rnr2p–Rnr4p subcellu-
lar compartmentalization data share similar dependencies on the
MEC1 pathway genes [14]. The localization to the same cellular
compartment may allow Hug1p to interact with Rnr2p–Rnr4p
through an undetermined, potentially inhibitory mechanism
(Fig. 4C) and downregulate Rnr activity. As seen in the model, in
cycling cells, Dif1p mediates the localization of Rnr2p–Rnr4p to
the nucleus where Wtm1p anchors it, while Sml1p inhibits the
activity of Rnr1p in the cytoplasm. After 1.5–2 h of HU induction,
Dif1p and Sml1p are phosphorylated and degraded; Rnr2p–Rnr4p
is exported from the nucleus to the cytoplasm where it forms the
active Rnr complex with the Rnr1p homodimer. After 3.5 h of HU
treatment, the high level of Hug1p expression and its localization
to the cytoplasm and co-compartmentalization with the Rnr com-
plex serve to downregulate Rnr activity and, potentially, dNTP
pools. The delayed expression of Hug1p to replication arrest and
co-compartmentalization with Rnr2p–Rnr4p may act to negatively
regulate Rnr activity in the absence of negative MEC1 effectors,
DIF1 and SML1, and permit cellular recovery in post-stress condi-
tions. Taken together, our data define a novel role for HUG1 in
the DNA damage and replication arrest pathway.
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wild-type (WT, W1588-4A), sml1D (U952-3B), and mec1Dsml1D (U953-61A) strains expressing GAL1-HUG1-GFP (pMB830) grown with or without galactose (GAL) in the
absence or in the presence of 0.1 M HU for 3.5 h probed with anti-GFP or -Tub1p (loading control). (B) Hug1p-GFP subcellular localization pattern as quantified by
fluorescence microscopy (as described in Section 2 and [22]) of wild-type (WT, YMB888), sml1D (U952-3B), mec1D sml1D (U953-61A), dun1D (U971) and rad53D (U960-5C)
expressing GAL1-HUG1-GFP (pMB830) grown in galactose medium with or without 0.1 M HU for 3.5 h. The graph shows means of three replicates with at least 100 cells
counted per experiment. Asterisks (*) indicate significant difference when compared to respective wild-type cells (Tukey’s HSD; p < 0.05). (C) Delayed induction and
cytoplasmic localization of Hug1p in response to HU treatment may serve to downregulate Rnr complex activity. Rnr complex with solid outline indicates catalytically active
form, while the one with dashed outline designates catalytically inactive form. Dif1p mediates the localization of Rnr2p–Rnr4p to the nucleus where Wtm1p anchors it, while
Sml1p inhibits the activity of Rnr1p in the cytoplasm. Dif1p and Sml1p are phosphorylated and degraded in response to HU treatment and Rnr2p–Rnr4p localizes to the
cytoplasm for catalytic activity. The delayed induction of Hug1p and its cytoplasmic localization and co-compartmentalization with the Rnr complex may serve to
downregulate Rnr activity and facilitate recovery from checkpoint response.
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